Skip to main content
IDEAYA Biosciences, Inc. (FRA:30J)
Germany flag Germany · Delayed Price · Currency is EUR
29.40
+0.60 (2.08%)
Last updated: Dec 4, 2025, 8:05 AM CET

IDEAYA Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
 TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2017
Period Ending
 Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2017
Net Income
-160.74-274.48-112.96-58.66-49.76-34.5
Upgrade
Depreciation & Amortization
4.043.834.013.523.031.38
Upgrade
Loss (Gain) From Sale of Assets
-----0
Upgrade
Loss (Gain) From Sale of Investments
-13.37-23.23-11.55-0.71.830.56
Upgrade
Stock-Based Compensation
43.8134.7518.4911.638.243.61
Upgrade
Change in Accounts Receivable
0.020.020.190.890.77-1.88
Upgrade
Change in Accounts Payable
6.538.282.641.861.170.23
Upgrade
Change in Unearned Revenue
2.17--13.75-46.48-23.5483.77
Upgrade
Change in Other Net Operating Assets
15.293.25-2.280.752.482.29
Upgrade
Operating Cash Flow
-102.26-247.58-115.22-87.18-55.7855.46
Upgrade
Capital Expenditures
-3.14-3.86-2.37-3.44-2.64-0.49
Upgrade
Investment in Securities
-26.47-498.7-156.09-29.96-67.02-145.75
Upgrade
Investing Cash Flow
-29.61-502.56-158.46-33.4-69.67-146.24
Upgrade
Issuance of Common Stock
30.4668.15320.5497.17145.45128.75
Upgrade
Other Financing Activities
-9.442.18---
Upgrade
Financing Cash Flow
30.4677.55362.7297.17145.45128.75
Upgrade
Net Cash Flow
-101.46-72.5989.04-23.4120.0137.97
Upgrade
Free Cash Flow
-105.39-251.44-117.59-90.62-58.4254.97
Upgrade
Free Cash Flow Margin
-49.06%-3592.01%-502.85%-177.92%-209.09%281.35%
Upgrade
Free Cash Flow Per Share
-1.20-3.08-2.04-2.19-1.662.22
Upgrade
Cash Interest Paid
-0.030.070.060.070.08
Upgrade
Cash Income Tax Paid
----00
Upgrade
Levered Free Cash Flow
-65.9-155.09-70.28-42.37-15.6411.39
Upgrade
Unlevered Free Cash Flow
-65.9-155.09-70.28-42.37-15.6411.39
Upgrade
Change in Working Capital
2411.55-13.21-42.97-19.1284.41
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.